2020
DOI: 10.4103/bc.bc_58_19
|View full text |Cite
|
Sign up to set email alerts
|

Multiphase adjuvant neuroprotection: A novel paradigm for improving acute ischemic stroke outcomes

Abstract: While several large pivotal clinical trials recently revealed a substantial benefit of endovascular thrombectomy for acute ischemic stroke (AIS) caused by large-vessel occlusion, many patients still experience mediocre prognosis. Enlargement of the ischemic core, failed revascularization, incomplete reperfusion, distal embolization, and secondary reperfusion injury substantially impact the salvaging of brain tissue and the functional outcomes of AIS. Here, we propose novel concept of "Multiphase Adjuvant Neuro… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
9
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
9

Relationship

5
4

Authors

Journals

citations
Cited by 47 publications
(10 citation statements)
references
References 100 publications
(108 reference statements)
1
9
0
Order By: Relevance
“…that edema-corrected infarct progression could be caused by other factors such as unsuccessful recanalization, no-reflow phenomenon, thrombus fragmentation, and/or formation of microvascular emboli (6). This could be supported by our finding that the 24-h lesion characteristics only showed a similar trend in the sub-population of unsuccessful recanalization.…”
Section: Discussionsupporting
confidence: 80%
See 1 more Smart Citation
“…that edema-corrected infarct progression could be caused by other factors such as unsuccessful recanalization, no-reflow phenomenon, thrombus fragmentation, and/or formation of microvascular emboli (6). This could be supported by our finding that the 24-h lesion characteristics only showed a similar trend in the sub-population of unsuccessful recanalization.…”
Section: Discussionsupporting
confidence: 80%
“…In patients with unsuccessful or incomplete recanalization, the evolving lesion is expected to predominantly consist of increasing infarct volume, possibly due to the expansion of infarct into the downstream territory caused by persistently reduced blood flow (2). Conversely, in patients with successful recanalization, the evolving lesions may consist of more edematous volume growth as a result of reperfusion injury and status of the microvasculature (6). Distinguishing between infarct and edema volumes (EV) may provide insight on the constituents of subacute lesion growth and help to understand the influence of subacute lesion progression on unfavorable outcome to better target secondary treatments.…”
Section: Introductionmentioning
confidence: 99%
“…At present, the effective methods of revascularization are thrombolysis and thrombectomy. However, the clinical efficacy of these therapies is limited by the narrow time window, potential complications and reperfusion injuries such as hemorrhagic transformation and brain edema ( 3 , 27 29 ). Exploring fast and effective neuroprotective strategies to earn time for vascular recanalization and reduce reperfusion injuries has become an essential desire in AIS treatment.…”
Section: Discussionmentioning
confidence: 99%
“…One general conclusion would be that there is a low likelihood of success in targeting one pathway or one selective mechanism within a rather heterogeneous, nongenetically determined condition operative over many years (44). Ischemic stroke-induced brain injury results from the interaction of complex pathophysiological processes such as excitotoxicity, oxidative stress, inflammation, and apoptosis (9, [45][46][47]. The post-ischemic cascade is a complex, multipathway, multifactorial process involving a variety of pathological mechanisms; therefore, multiple targets of neuroprotection drugs may be more effective.…”
Section: Discussionmentioning
confidence: 99%